PARIS, Jan 4 (Reuters) - France has started measures to suspend sales of a product known as Uvesterol D, used for Vitamin D deficiency, after the death of a baby who had been given a dose of it, a French medical safety watchdog said on Wednesday.
“The conclusions of investigations so far show evidence pointing to a probable link between the death, and the dose of Uvesterol D that was administered,” the medical safety agency ANSM said in a statement.
Uvesterol D is developed by the Crinex laboratory.
Officials at Crinex could not be immediately reached for comment.
Reporting by Sudip Kar-Gupta and Eric Faye; Editing by Robert Birsel